Dementia diagnostic and treatment services in the Western Pacific: challenges, preparedness and opportunities in the face of amyloid-targeting therapies
Lists
Only you see this
Abstract
Here we first review the limited available literature addressing the current landscape of specialist assessment services for dementia and cognitive decline and the preparedness for new amyloid-targeting therapies for Alzheimer's disease across the Western Pacific region. Considering the scarcity of literature, as national representatives of Western Pacific nations we were then guided by the World Health Organization's Global Action Plan on Dementia to provide country-specific reviews. As a whole, we highlight that the existing diverse socioeconomic and cultural landscape across the region poses unique challenges, including varying access to services and marked differences among countries in their preparedness for upcoming amyloid-targeting therapies for Alzheimer's disease. Therefore, there is an urgent call for intergovernmental collaboration and investment across the Western Pacific to ensure that for all nations, citizens living with dementia and cognitive decline have access to effective and equitable methods of diagnosis, treatment and care.
BibTeX
@inproceedings{ocallaghan2024dementia,
author = {Claire O’Callaghan and Johannes C. Michaelian and Yoko Aihara and Veeda Michelle M. Anlacan and Christopher Chen and Gary Cheung and Etuini Ma’u and Tuan Anh Nguyen and Ming‐Chyi Pai and Anna Palagyi and Maw Pin Tan and Shyh Poh Teo and Yuda Turana and Huali Wang and Gloria Hoi Yan Wong and Sharon L. Naismith},
title = {{Dementia diagnostic and treatment services in the Western Pacific: challenges, preparedness and opportunities in the face of amyloid-targeting therapies}},
booktitle = {The Lancet Regional Health - Western Pacific},
year = {2024},
doi = {10.1016/j.lanwpc.2024.101183},
}Loading related content...